The Aquatic Animal Drug Approval Partnership (AADAP) program wants to expand the U.S. Food and Drug Administration approved label for Halamid Aqua (100% chloramine-T). In order to do this, they need to generate the following field effectiveness studies that will be both acceptable to FDA and help support expanding the label:

Study 1:  Use of chloramine-T to control mortality in any species of freshwater-reared salmonid due to columnaris disease

Study 2:  Use of chloramine-T to control mortality in any species on freshwater-reared non-salmonids due to bacterial gill disease.

If you are interested in assisting with either study, AADAP will work with you to conduct the study. Whether that involves providing fish test tanks, having staff come out to your facility to get the study started or coordinating fish health diagnosis.  AADAP staff will also analyze the data, write the report, and get it submitted to FDA.

Expanding the Halamid Aqua label will not be possible without help from industry partners.  Please contact AADAP if you are interested.